Comparison of the radiolabeled PSMA-inhibitor 111In-PSMA-617 and the radiolabeled GRP-R antagonist 111In-RM2 in primary prostate cancer samples

Purpose Prostate-specific membrane antigen (PSMA) and gastrin-releasing peptide receptor (GRP-R) are expressed in prostate cancer and can be targeted with radiolabeled inhibitors and antagonists. Their performances for the initial characterization of prostatic tumors have been barely evaluated but n...

Full description

Saved in:

Bibliographic Details
Published in:	EJNMMI research Vol. 9; no. 1; pp. 1 - 7
Main Authors:	Schollhammer, Romain, De Clermont Gallerande, Henri, Yacoub, Mokrane, Quintyn Ranty, Marie-Laure, Barthe, Nicole, Vimont, Delphine, Hindié, Elif, Fernandez, Philippe, Morgat, Clément
Format:	Journal Article
Language:	English
Published:	Berlin/Heidelberg Springer Berlin Heidelberg 03.06.2019 Springer Nature B.V SpringerOpen
Subjects:	Antigens Binding Cancer surgery Cardiac Imaging GRP-R Histology Imaging Inhibitors Medicine Medicine & Public Health Metastasis Nuclear Medicine Oncology Original Research Orthopedics Prostate cancer PSMA Radiology Tracers Tumors GRP-R Prostate cancer PSMA
ISSN:	2191-219X, 2191-219X
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!